https://mobile.nytimes.com/2017/04/06/health/fda-genetic-tests-23andme.html
For the first time, the Food and Drug Administration said it would allow a company to sell genetic tests for disease risk directly to consumers, providing people with information about the likelihood that they could develop various conditions, including Parkinson's and Alzheimer's.
The move on Thursday is a turnaround for the agency, which had imposed a moratorium in 2013 on disease tests sold by the company, 23andMe, which is based in Mountain View, Calif. The decision is expected to open the floodgates for more direct-to-consumer tests for disease risks, drawing a road map for other companies to do the same thing.
If you could take such a test, would you? Or would you rather just take things as they come?
(Score: 2) by gringer on Sunday April 09 2017, @02:38AM
If you don't mind a $2000 cost, you can do that yourself with the MinION (assuming you have access to pipettes and minicentrifuges).
If you can find another 11 like-minded people, you can split the sequencing 12 ways with a barcoding kit, and reduce the consumable cost to about $200 per person. Coverage would be lower, but will be sufficient to pick up a few structural variants and maybe a few at the sequence level as well.
Ask me about Sequencing DNA in front of Linus Torvalds [youtube.com]